{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:34:30Z","timestamp":1784302470794,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> This study aims to explore the difference of clinical efficacy and psychological flexibility of sertraline hydrochloride combined with acceptance and commitment therapy (ACT) or repeated transcranial magnetic stimulation (rTMS) in patients with obsessive\u2013compulsive disorder (OCD).<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> Sixty-three inpatients diagnosed with OCD were randomly divided into ACT group (<jats:italic>N<\/jats:italic> = 32) and rTMS group (<jats:italic>N<\/jats:italic> = 31), both of which were combined with sertraline hydrochloride. The following assessments were completed by the Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Yale\u2013Brown Obsessive Compulsive Scale (Y-BOCS), Symptom Checklist 90 (SCL-90), Acceptance and Action Questionnaire (AAQ-II), and Cognitive Fusion Questionnaire (CFQ) during pretreatment, 4 weeks posttreatment, and 8-week follow-up.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> After treatment: (1) the SCL-90 score of two groups significantly decreased from pretreatment to 8-week follow-up (<jats:italic>P<\/jats:italic> &amp;lt; 0.01 and <jats:italic>P<\/jats:italic> &amp;lt; 0.001); (2) The HAMA, HAMD, and Y-BOCS scores of the two groups significantly decreased from pretreatment to 8-week follow-up (<jats:italic>P<\/jats:italic> &amp;lt; 0.001 and <jats:italic>P<\/jats:italic> &amp;lt; 0.05); (3) No statistically significant difference of the SCL-90, HAMA, HAMD and Y-BOCS between two groups; (4) The AAQ-II and CFQ scores of the ACT group significantly decreased from 4 weeks posttreatment to 8-week follow-up (<jats:italic>P<\/jats:italic> &amp;lt; 0.01). However, no statistically significant difference was observed in the rTMS group (<jats:italic>P<\/jats:italic> &amp;gt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Overall, our study suggested that sertraline hydrochloride combined with ACT or rTMS can improve the obsessive\u2013compulsive symptoms, anxiety, and depression and has equivalent efficacy. Moreover, ACT can more effectively and durably improve the psychological flexibility of patients compared with rTMS.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.720518","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T06:55:19Z","timestamp":1641970519000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive\u2013Compulsive Disorder"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingzhi","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maorong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive-compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1570159X16666180813155017","article-title":"Psychopharmacological treatment of obsessive-compulsive disorder (OCD)","volume":"17","author":"Del Casale","year":"2019","journal-title":"Curr Neuropharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2016.07.030","article-title":"Cognitive inflexibility in obsessive-compulsive disorder","volume":"345","author":"Gruner","year":"2017","journal-title":"Neuroscience."},{"key":"B4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cub.2020.10.045","article-title":"Dysfunction of orbitofrontal GABAergic interneurons leads to impaired reversal learning in a mouse model of obsessive-compulsive disorder","volume":"31","author":"Yang","year":"2021","journal-title":"Curr Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.psychres.2017.03.001","article-title":"Reversal learning in patients with obsessive-compulsive disorder (OCD) and their unaffected relatives: is orbitofrontal dysfunction an endophenotype of OCD?","volume":"252","author":"Tezcan","year":"2017","journal-title":"Psychiatry Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fpsyt.2019.00523","article-title":"The effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: a systematic review and meta-analysis","volume":"10","author":"Kotapati","year":"2019","journal-title":"Front Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.4088\/JCP.14r09758","article-title":"Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis","volume":"77","author":"Issari","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopsych.2011.12.028","article-title":"Similar improvement of reward and punishment learning by serotonin reuptake inhibitors in obsessive-compulsive disorder","volume":"72","author":"Palminteri","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0004867412461958","article-title":"Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond","volume":"47","author":"Fineberg","year":"2013","journal-title":"Aust New Zealand J Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2018.0930","article-title":"Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review","volume":"75","author":"Dougherty","year":"2018","journal-title":"JAMA Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.2174\/0929867325666171222163645","article-title":"A systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy","volume":"25","author":"Albert","year":"2018","journal-title":"Curr Med Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2174\/1570159X17666190409142555","article-title":"Brain stimulation in obsessive-compulsive disorder (OCD): a systematic review","volume":"17","author":"Rapinesi","year":"2019","journal-title":"Curr Neuropharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.biopsych.2014.12.010","article-title":"Presupplementary motor area contributes to altered error monitoring in obsessive-compulsive disorder","volume":"80","author":"Gr\u00fctzmann","year":"2016","journal-title":"Biol Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jad.2015.12.071","article-title":"Graph-theoretical analysis of resting-state fMRI in pediatric obsessive-compulsive disorder","volume":"193","author":"Armstrong","year":"2016","journal-title":"J Affect Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1503\/jpn.180064","article-title":"Changes of motor cortical excitability and response inhibition in patients with obsessive\u2013compulsive disorder","volume":"44","author":"Kang","year":"2019","journal-title":"J Psychiatry Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1176\/appi.ajp.2012.12010073","article-title":"Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder","volume":"169","author":"de Wit","year":"2012","journal-title":"Am J Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4306\/jknpa.2016.55.3.158","article-title":"Application of transcranial direct current stimulation in psychiatry","volume":"55","author":"Kim","year":"2016","journal-title":"J Korean Neuropsychiatr Assoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41398-021-01453-0","article-title":"Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"11","author":"Liang","year":"2021","journal-title":"Transl Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12888-020-02769-9","article-title":"Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study","volume":"20","author":"Rostami","year":"2020","journal-title":"BMC Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/0269881116628427","article-title":"Better than treated as usual: transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive- compulsive disorder, mini-review and pilot open-label trial","volume":"30","author":"Pallanti","year":"2016","journal-title":"J Psychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/14737175.2020.1798232","article-title":"Deep transcranial magnetic stimulation for obsessive compulsive disorder","volume":"20","author":"McCathern","year":"2020","journal-title":"Expert Rev Neurother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaac.2019.08.480","article-title":"Systematic review and meta-analysis: cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents","volume":"59","author":"Uhre","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"102151","DOI":"10.1016\/j.janxdis.2019.102151","article-title":"Cost-effectiveness of treatment alternatives for treatment-refractory pediatric obsessive-compulsive disorder","volume":"69","author":"Gregory","year":"2020","journal-title":"J Anxiety Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jad.2019.09.040","article-title":"Acceptance and Commitment Therapy (ACT) to reduce depression: a systematic review and meta-analysis","volume":"260","author":"Bai","year":"2020","journal-title":"J Affect Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/papt.12233","article-title":"Examining the role of cognitive fusion and experiential avoidance in predicting anxiety and depression","volume":"93","author":"Cookson","year":"2020","journal-title":"Psychol Psychother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jad.2019.11.154","article-title":"Acceptance and commitment therapy in group format for anxiety and depression. A systematic review","volume":"263","author":"Coto-Lesmes","year":"2020","journal-title":"J Affect Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.psc.2017.08.009","article-title":"Acceptance and commitment therapy as a treatment for anxiety and depression: a review","volume":"40","author":"Twohig","year":"2017","journal-title":"Psychiatr Clin North Am."},{"key":"B28","first-page":"2519","article-title":"Effectiveness of acceptance and commitment therapy in reduction of severity symptoms of patients with obsessive\u2013Compulsive disorder","volume":"8","author":"Baghooli","year":"2014","journal-title":"Adv Environ Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100440","DOI":"10.1016\/j.jocrd.2019.04.003","article-title":"An Iranian study of group acceptance and commitment therapy versus group cognitive behavioral therapy for adolescents with obsessive-compulsive disorder on an optimal dose of selective serotonin reuptake inhibitors","volume":"22","author":"Shabani","year":"2019","journal-title":"J Obsess Compuls Relat Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.rehab.2015.05.005","article-title":"Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)","volume":"58","author":"Klomjai","year":"2015","journal-title":"Ann Phys Rehabil Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11126-018-9566-7","article-title":"A meta-analysis of the effectiveness of different cortical targets used in repetitive transcranial magnetic stimulation (rTMS) for the treatment of obsessive-compulsive disorder (OCD)","volume":"89","author":"Rehn","year":"2018","journal-title":"Psychiatr Q."},{"key":"B32","volume-title":"The Cognitive Fusion Questionnaire: Further Developments in Measuring Cognitive Fusion","author":"Gillanders","year":"2010"},{"key":"B33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol Psychiatry."},{"key":"B34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.beth.2017.09.002","article-title":"New directions in the cognitive-behavioral treatment of OCD: theory, research, and practice","volume":"49","author":"Abramowitz","year":"2018","journal-title":"Behav Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.janxdis.2014.06.008","article-title":"Acceptance and commitment therapy for anxiety and OCD spectrum disorders: an empirical review","volume":"28","author":"Bluett","year":"2014","journal-title":"J Anxiety Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jocrd.2018.07.003","article-title":"Experiential avoidance in the context of obsessions: development and validation of the acceptance and action questionnaire for obsessions and compulsions","volume":"19","author":"Jacoby","year":"2018","journal-title":"J Obsess Compuls Relat Disord."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.720518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T06:55:22Z","timestamp":1641970522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.720518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":36,"alternative-id":["10.3389\/fpsyt.2021.720518"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.720518","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"article-number":"720518"}}